)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
JB Chemicals & Pharmaceuticals
JB Chemicals & Pharmaceuticals (506943) investor relations material
JB Chemicals & Pharmaceuticals Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary19 Jan, 2026
Executive summary
Q3 FY26 revenues grew 11% year-on-year to INR 1,065 crores, with net profit up 22% to INR 198 crores and operating EBITDA up 13% to INR 305 crores; domestic and international businesses outperformed the market, driven by chronic therapies and flagship brands.
Gross margin expanded by 200 basis points to 69.1%, and operating EBITDA margin improved to 28.7% year-on-year, supported by cost optimization and favorable product mix.
Priorities include strengthening flagship brands, accelerating chronic therapy growth, scaling CDMO, and building organizational resilience.
Unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, were reviewed and approved by the Board and auditors, with no material misstatements identified.
Financial highlights
Q3 FY26 revenue reached INR 1,065 crores, up 11% YoY; 9M FY26 revenue was INR 3,244 crores, up 9% YoY; net profit for Q3 FY26 rose 22% YoY to INR 198 crores.
Operating EBITDA for Q3 FY26 was INR 305 crores (up 13% YoY) with a margin of 28.7%; 9M FY26 EBITDA was INR 955 crores (up 13% YoY) with a margin of 29.4%.
Gross margin improved to 69.1% in Q3 FY26 (up 200 bps YoY); other income increased to INR 18 crores due to treasury income.
Standalone and consolidated net profit after tax for Q3 FY26 was ₹17,927 lakhs and ₹19,789 lakhs, respectively, with consolidated EPS at ₹12.63.
Paid-up equity share capital increased due to ESOS allotments.
Outlook and guidance
Operating margin guidance for FY26 remains at 27-29%, with gross margin for the year guided to be in the 60-69% range.
Domestic business expected to grow 200-300 basis points above the market, international business to end the year at high single-digit growth.
CDMO sales momentum expected to continue into Q4 FY26, with growth of 10-12% in FY27.
Q4 expected to maintain similar performance as Q3, with strong order books in both domestic and international markets.
The company continues to monitor regulatory changes, including new Labour Codes, and will adjust financial reporting as needed.
CCI modifications for Torrent acquisition
Labour Code impact beyond current charge
Risk from unreviewed subsidiary financials?
What is the Q4 ESOP charge from merger close?
CDMO FY27 growth outlook and plant utilization?
Impact of acute/gastro slowdown on domestic growth?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next JB Chemicals & Pharmaceuticals earnings date
Q4 25/2614 May, 2026
JB Chemicals & Pharmaceuticals
Next JB Chemicals & Pharmaceuticals earnings date
Q4 25/2614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
JB Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company engaged in the development, manufacturing, and marketing of a broad range of branded and generic formulations, as well as active pharmaceutical ingredients. The company’s product portfolio spans therapeutic areas such as cardiovascular, gastrointestinal, anti-infective, and pain management. It operates manufacturing facilities approved by international regulatory agencies and supplies products to both domestic and international markets. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage